Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

Drug persistence, effectiveness and safety assessment of anti-TNF therapies in psoriatic arthritis.

Saad AA, Hyrich KL, Ashcroft DM.

Expert Opin Drug Saf. 2011 Mar;10(2):219-26. doi: 10.1517/14740338.2010.516250. Epub 2011 Jan 6. Review.

PMID:
21208138
[PubMed - indexed for MEDLINE]
2.

TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.

Tobin AM, Kirby B.

BioDrugs. 2005;19(1):47-57. Review.

PMID:
15691217
[PubMed - indexed for MEDLINE]
3.

Safety of anti-tumor necrosis factor agents in psoriatic arthritis - an update.

Palazzi C, D'Angelo S, Leccese P, Padula A, Olivieri I.

Expert Opin Drug Saf. 2014 Feb;13(2):191-6. doi: 10.1517/14740338.2014.857655. Epub 2013 Nov 13. Review.

PMID:
24219428
[PubMed - indexed for MEDLINE]
4.

Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register.

Saad AA, Ashcroft DM, Watson KD, Hyrich KL, Noyce PR, Symmons DP; British Society for Rheumatology Biologics Register.

Arthritis Res Ther. 2009;11(2):R52. doi: 10.1186/ar2670. Epub 2009 Apr 8.

PMID:
19356232
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy.

Rudwaleit M, Van den Bosch F, Kron M, Kary S, Kupper H.

Arthritis Res Ther. 2010;12(3):R117. doi: 10.1186/ar3054. Epub 2010 Jun 16.

PMID:
20553600
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Psoriatic arthritis treatment: biological response modifiers.

Mease PJ, Antoni CE.

Ann Rheum Dis. 2005 Mar;64 Suppl 2:ii78-82. Review.

PMID:
15708944
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis.

Ash Z, Gaujoux-Viala C, Gossec L, Hensor EM, FitzGerald O, Winthrop K, van der Heijde D, Emery P, Smolen JS, Marzo-Ortega H.

Ann Rheum Dis. 2012 Mar;71(3):319-26. doi: 10.1136/ard.2011.150995. Epub 2011 Jul 28. Review.

PMID:
21803753
[PubMed - indexed for MEDLINE]
8.

[The role of biological agents in the treatment of psoriatic arthritis, literature review].

Koó E, Brodszky V, Péntek M, Ujfalussy I, Nagy MB, Gulácsi L.

Orv Hetil. 2006 Oct 15;147(41):1963-70. Review. Hungarian.

PMID:
17120686
[PubMed - indexed for MEDLINE]
9.

[New drugs and treatment strategies for rheumatoid arthritis].

Fantini F.

Recenti Prog Med. 2003 Sep;94(9):361-79. Review. Italian.

PMID:
12942798
[PubMed - indexed for MEDLINE]
10.

Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis.

Bansback NJ, Ara R, Barkham N, Brennan A, Fraser AD, Conway P, Reynolds A, Emery P.

Rheumatology (Oxford). 2006 Aug;45(8):1029-38. Epub 2006 Jun 16.

PMID:
16782734
[PubMed - indexed for MEDLINE]
Free Article
11.

Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial.

Gladman DD, Mease PJ, Ritchlin CT, Choy EH, Sharp JT, Ory PA, Perdok RJ, Sasso EH.

Arthritis Rheum. 2007 Feb;56(2):476-88.

PMID:
17265483
[PubMed - indexed for MEDLINE]
Free Article
12.

Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor therapies.

Saad AA, Ashcroft DM, Watson KD, Symmons DP, Noyce PR, Hyrich KL; British Society for Rheumatology Biologics Register.

Arthritis Care Res (Hoboken). 2010 Mar;62(3):345-53. doi: 10.1002/acr.20104.

PMID:
20391480
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Systematic literature review on economic implications and pharmacoeconomic issues of psoriatic arthritis.

Cortesi PA, Scalone L, D'Angiolella L, Belisari A, Fusco F, Olivieri I, Mantovani LG.

Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S126-31. Epub 2012 Oct 18. Review.

PMID:
23072771
[PubMed - indexed for MEDLINE]
14.

The treatment of psoriatic arthritis and inflammatory spondylitis.

Castro-Rueda H, Kavanaugh A.

Curr Pain Headache Rep. 2008 Dec;12(6):412-7. Review.

PMID:
18973733
[PubMed - indexed for MEDLINE]
15.

Treatment of psoriatic arthritis with biological agents.

Ceponis A, Kavanaugh A.

Semin Cutan Med Surg. 2010 Mar;29(1):56-62. doi: 10.1016/j.sder.2010.01.004. Review.

PMID:
20430309
[PubMed - indexed for MEDLINE]
16.

Modelling the cost effectiveness of TNF-alpha antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry.

Brennan A, Bansback N, Nixon R, Madan J, Harrison M, Watson K, Symmons D.

Rheumatology (Oxford). 2007 Aug;46(8):1345-54. Epub 2007 Jun 11.

PMID:
17562686
[PubMed - indexed for MEDLINE]
Free Article
17.

The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study.

Heiberg MS, Kaufmann C, Rødevand E, Mikkelsen K, Koldingsnes W, Mowinckel P, Kvien TK.

Ann Rheum Dis. 2007 Aug;66(8):1038-42. Epub 2007 Jan 9.

PMID:
17213251
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Recommendations of the Italian Society for Rheumatology for the use of biologic (TNF-alpha blocking) agents in the treatment of psoriatic arthritis.

Salvarani C, Olivieri I, Pipitone N, Cantini F, Marchesoni A, Punzi L, Scarpa R, Matucci-Cerinic M; Italian Society for Rheumatology.

Clin Exp Rheumatol. 2006 Jan-Feb;24(1):70-8.

PMID:
16539822
[PubMed - indexed for MEDLINE]
19.

Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register.

Kristensen LE, Gülfe A, Saxne T, Geborek P.

Ann Rheum Dis. 2008 Mar;67(3):364-9. Epub 2007 Jul 20.

PMID:
17644547
[PubMed - indexed for MEDLINE]
20.

Golimumab for the treatment of psoriatic arthritis.

Yang H, Epstein D, Bojke L, Craig D, Light K, Bruce I, Sculpher M, Woolacott N.

Health Technol Assess. 2011 May;15 Suppl 1:87-95. doi: 10.3310/hta15suppl1/10. Review.

PMID:
21609657
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk